
### [MONDO:0018965](http://purl.obolibrary.org/obo/MONDO_0018965)
**Label:** Alport syndrome

**Subclasses:** [MONDO:0008762](http://purl.obolibrary.org/obo/MONDO_0008762) (autosomal recessive Alport syndrome), [MONDO:0010520](http://purl.obolibrary.org/obo/MONDO_0010520) (X-linked Alport syndrome), [MONDO:0007086](http://purl.obolibrary.org/obo/MONDO_0007086) (autosomal dominant Alport syndrome), 

**Corr. equiv. classes:** [OMIM:203780](http://purl.obolibrary.org/obo/OMIM_203780), [Orphanet:88918](http://www.orpha.net/ORDO/Orphanet_88918), [Orphanet:88919](http://www.orpha.net/ORDO/Orphanet_88919), [Orphanet:88917](http://www.orpha.net/ORDO/Orphanet_88917), [OMIM:104200](http://purl.obolibrary.org/obo/OMIM_104200), [OMIM:301050](http://purl.obolibrary.org/obo/OMIM_301050), 

**Class expressions from DL-Learner:**

- [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) and [HP:0030972](http://purl.obolibrary.org/obo/HP_0030972) (Abnormal systemic blood pressure) 75.00%
- [HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0012649](http://purl.obolibrary.org/obo/HP_0012649) (Increased inflammatory response) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0012647](http://purl.obolibrary.org/obo/HP_0012647) (Abnormal inflammatory response) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0011025](http://purl.obolibrary.org/obo/HP_0011025) (Abnormality of cardiovascular system physiology) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0010978](http://purl.obolibrary.org/obo/HP_0010978) (Abnormality of immune system physiology) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0003679](http://purl.obolibrary.org/obo/HP_0003679) (Pace of progression) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0003676](http://purl.obolibrary.org/obo/HP_0003676) (Progressive) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0002715](http://purl.obolibrary.org/obo/HP_0002715) (Abnormality of the immune system) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0000822](http://purl.obolibrary.org/obo/HP_0000822) (Hypertension) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0000545](http://purl.obolibrary.org/obo/HP_0000545) (Myopia) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0000539](http://purl.obolibrary.org/obo/HP_0000539) (Abnormality of refraction) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%
- [HP:0000123](http://purl.obolibrary.org/obo/HP_0000123) (Nephritis) and [HP:0030034](http://purl.obolibrary.org/obo/HP_0030034) (Diffuse glomerular basement membrane lamellation) 75.00%


